TL;DR: LEAH Labs is a Y Combinator Winter 2019 startup Living therapies for pets first, and their people next, currently active with a team of 4.
Living therapies for pets first, and their people next
Last verified:
LEAH Labs is building living therapies for pets first, and their people next. We're first focused on CAR-T cell therapy for dogs with B cell lymphoma, the naturally occurring clinical analog of human non-Hodgkin's lymphoma. CAR-T cells are curative in humans, and our early results are showing the same - we're inducing remissions in pets with late stage lymphomas. Our virus-free gene editing platform allows us to engineer a dose of CAR-T cell therapy for ~$500, and brings the promise of a curative outcome. Given our safety and efficacy data to date, we believe this product could be used by general practice veterinarians, meaning we have thousands of customers all across the USA who typically treat with palliative care or refer cancer patients to specialty oncologists. Our CAR-T cell platfo…
Built by LemStudio
Yes. LEAH Labs was funded by Y Combinator in the Winter 2019 batch. Living therapies for pets first, and their people next
LEAH Labs is building living therapies for pets first, and their people next. We're first focused on CAR-T cell therapy for dogs with B cell lymphoma, the naturally occurring clinical analog of human non-Hodgkin's lymphoma. CAR-T cells are curative in humans, and our early results are showing the same - we're inducing…
LEAH Labs was part of Y Combinator's Winter 2019 batch.
LEAH Labs has a team of 4 people according to Y Combinator's directory.
LEAH Labs is currently listed as Active with a team of 4 in Y Combinator's directory.
Loading interactive view…